| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer. | Cancer Chemother Pharmacol | 2010 | 0.83 |
| 2 | Is nasobiliary drainage unnecessary for drainage of acute suppurative cholangitis? Our experience. | Dig Endosc | 2010 | 0.78 |
| 3 | A case of solid-pseudopapillary neoplasm, focusing on contrast-enhanced endoscopic ultrasonography. | J Med Ultrason (2001) | 2011 | 0.75 |
| 4 | Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer. | Cancer Chemother Pharmacol | 2017 | 0.75 |